Advancing Desmoid Tumor Science
The DTRF funds research that will advance current scientific knowledge about desmoid tumors, moving toward the development of new treatment options and bringing us closer to our ultimate goal of a cure for each and every patient with a desmoid tumor. The Foundation is particularly interested in innovative and translational research projects and will consider applications across the spectrum of research from basic science to clinical trials and correlative studies.
- Letter of Intent due: March 11, 2024. See LOI guidelines within the RFP.
- Full Application due: April 15, 2024
Request for Proposals
Learn more about the DTRF Dr. Dina Lev Early Career Investigator Grant, named in honor of Dina Chelouche Lev, MD, an early leader in desmoid tumor research.
Desmoid Cell Line at ATCC
Publicly available desmoid tumor immortal cell lines are now available for purchase at ATCC, a public biorepository based in Manassas, VA. These tumor-derived models can be used in basic research as well as pharmacological screening applications. Detailed information about these models can be found on the ATCC website and on the HCMI website. Discounted pricing is available to academic researchers.
Clinicians & Researchers Newsletter
Receive monthly updates about treatment advances, grant applications, clinical trials, CME opportunities, and more.